Artwork

コンテンツは Labiotech によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Labiotech またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal
Player FM -ポッドキャストアプリ
Player FMアプリでオフラインにしPlayer FMう!

How biotech is tackling myasthenia gravis

28:50
 
シェア
 

Manage episode 419977836 series 3361449
コンテンツは Labiotech によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Labiotech またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

June is myasthenia gravis awareness month. Myasthenia gravis is a chronic autoimmune disorder where antibodies destroy the communication between nerves and muscle, and this results in weakness of the skeletal muscles.

It especially affects the voluntary muscles of the eyes, mouth, throat and/or limbs. It is most frequent in women from 20 and 30 and men aged 50 and older.

To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.

01:07-04:26: Background on Dr Dana Vigier
04:26-07:07: What is myasthenia gravis?
07:07-09:43: What is the prognosis for someone diagnosed with myasthenia gravis?
09:43-11:33: How effective are current treatments for myasthenia gravis?
11:33-12:56: Do all the myasthenia gravis drugs work in the same way?
12:56-18:35: What R&D is taking place in myasthenia gravis?
18:35-21:14: Alexion and its work on myasthenia gravis
21:14-22:01: Myasthenia gravis clinical trials
22:01-23:58: The importance of myasthenia gravis awareness month
23:58-25:31: Would early diagnosis make a difference?
25:31-27:54: Transformation through new treatments
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

  continue reading

1. How biotech is tackling myasthenia gravis (00:00:00)

2. Background on Dr Dana Vigier
 (00:01:07)

3. What is myasthenia gravis?
 (00:04:26)

4. What is the prognosis for someone diagnosed with myasthenia gravis?
 (00:07:07)

5. How effective are current treatments for myasthenia gravis?
 (00:09:43)

6. Do myasthenia gravis drugs work in the same way? 
 (00:11:33)

7. What R&D is taking place in myasthenia gravis?
 (00:12:56)

8. Alexion and its work on myasthenia gravis
 (00:18:35)

9. Myasthenia gravis clinical trials
 (00:21:14)

10. The importance of myasthenia gravis awareness month
 (00:22:01)

11. Would early diagnosis of myasthenia gravis make a difference? (00:23:58)

12. Transformation through new treatments (00:25:31)

103 つのエピソード

Artwork
iconシェア
 
Manage episode 419977836 series 3361449
コンテンツは Labiotech によって提供されます。エピソード、グラフィック、ポッドキャストの説明を含むすべてのポッドキャスト コンテンツは、Labiotech またはそのポッドキャスト プラットフォーム パートナーによって直接アップロードされ、提供されます。誰かがあなたの著作物をあなたの許可なく使用していると思われる場合は、ここで概説されているプロセスに従うことができますhttps://ja.player.fm/legal

June is myasthenia gravis awareness month. Myasthenia gravis is a chronic autoimmune disorder where antibodies destroy the communication between nerves and muscle, and this results in weakness of the skeletal muscles.

It especially affects the voluntary muscles of the eyes, mouth, throat and/or limbs. It is most frequent in women from 20 and 30 and men aged 50 and older.

To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.

01:07-04:26: Background on Dr Dana Vigier
04:26-07:07: What is myasthenia gravis?
07:07-09:43: What is the prognosis for someone diagnosed with myasthenia gravis?
09:43-11:33: How effective are current treatments for myasthenia gravis?
11:33-12:56: Do all the myasthenia gravis drugs work in the same way?
12:56-18:35: What R&D is taking place in myasthenia gravis?
18:35-21:14: Alexion and its work on myasthenia gravis
21:14-22:01: Myasthenia gravis clinical trials
22:01-23:58: The importance of myasthenia gravis awareness month
23:58-25:31: Would early diagnosis make a difference?
25:31-27:54: Transformation through new treatments
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!

Stay updated by subscribing to our newsletter

  continue reading

1. How biotech is tackling myasthenia gravis (00:00:00)

2. Background on Dr Dana Vigier
 (00:01:07)

3. What is myasthenia gravis?
 (00:04:26)

4. What is the prognosis for someone diagnosed with myasthenia gravis?
 (00:07:07)

5. How effective are current treatments for myasthenia gravis?
 (00:09:43)

6. Do myasthenia gravis drugs work in the same way? 
 (00:11:33)

7. What R&D is taking place in myasthenia gravis?
 (00:12:56)

8. Alexion and its work on myasthenia gravis
 (00:18:35)

9. Myasthenia gravis clinical trials
 (00:21:14)

10. The importance of myasthenia gravis awareness month
 (00:22:01)

11. Would early diagnosis of myasthenia gravis make a difference? (00:23:58)

12. Transformation through new treatments (00:25:31)

103 つのエピソード

すべてのエピソード

×
 
Loading …

プレーヤーFMへようこそ!

Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。

 

クイックリファレンスガイド